GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial ...
TipRanks on MSN
Protalix Seeks EMA Re-examination for Elfabrio Dosing
Protalix ( ($PLX) ) has issued an update. On November 3, 2025, Protalix BioTherapeutics and Chiesi Global Rare Diseases announced their request ...
A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...
A case of membranoproliferative glomerulonephritis with immune depositions in the kidney was reported during clinical trials. Monitor serum creatinine and urinary protein-to-creatinine ratio. If ...
ISELIN, N.J., Nov. 03, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of retina diseases, today ...
Savara Inc. (the "Company"), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced members of the management team will host 1x1 meetings and participate in ...
Lumen Biosciences Brian Finrow breaks down Chinas biotech playbook and explores ways the U.S. can adapt it for its own continued success.
Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light ...
Medytox announced on the 4th that it participated in the academic conference 'ICLAS,' hosted by the Korean Society for Laser ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on optimizing the standard of care for bevacizumab for the treatment of ...
Chile is home to one of the world’s largest salmon-farming industries, making it a vital hub for aquaculture vaccine demand. Salmon alone accounts for about 85 % of the vaccines used in Chile’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback